CLOV CLOVER HEALTH INVESTMENTS CO revenue, earnings and financials
For the quarter ended June 30, 2026, CLOVER HEALTH INVESTMENTS CO reported revenue of $743M (up 55.6% from a year earlier), net income of $28.0M and diluted EPS of $0.05; over the last four quarters revenue was $2.48B and net income −$18.4M; for the fiscal year ended December 2025 revenue was $1.92B, up 40.3% on the year before.
CLOV annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.92B, gross profit n/a, operating income −$85.5M, net income −$85.5M (margin -4.4%), EPS n/a
- Fiscal year ended Dec 2024: revenue $1.37B, gross profit n/a, operating income −$45.7M, net income −$43.0M (margin -3.1%), EPS n/a
- Fiscal year ended Dec 2023: revenue $1.26B, gross profit $257M, operating income −$205M, net income −$213M (margin -16.9%), EPS −$0.44
- Fiscal year ended Dec 2022: revenue $1.10B, gross profit $70.2M, operating income −$287M, net income −$339M (margin -30.9%), EPS −$0.71
- Fiscal year ended Dec 2021: revenue $1.47B, gross profit −$79.2M, operating income −$637M, net income −$588M (margin -39.9%), EPS −$1.42
CLOV quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $743M (up 55.6% year over year), net income $28.0M, EPS $0.05
- Quarter ended Mar 31, 2026: revenue $749M (up 62.0% year over year), net income $27.3M, EPS $0.05
- Quarter ended Dec 31, 2025 (from the annual report): revenue $488M (up 44.7% year over year), net income −$49.3M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $497M (up 50.1% year over year), net income −$24.4M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $478M (up 34.1% year over year), net income −$10.6M, EPS −$0.02
- Quarter ended Mar 31, 2025: revenue $462M (up 33.3% year over year), net income −$1.27M, EPS $0.00
- Quarter ended Dec 31, 2024 (from the annual report): revenue $337M (up 7.9% year over year), net income −$22.1M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $331M (up 8.2% year over year), net income −$9.16M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $356M (up 11.3% year over year), net income $7.41M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $347M (up 7.7% year over year), net income −$19.2M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $312M (up 121.1% year over year), net income −$70.5M, EPS −$0.14
- Quarter ended Sep 30, 2023: revenue $306M (down 64.3% year over year), net income −$41.5M, EPS −$0.09
- Quarter ended Jun 30, 2023: revenue $320M (down 62.2% year over year), net income −$28.8M, EPS −$0.06
- Quarter ended Mar 31, 2023: revenue $322M (down 63.2% year over year), net income −$72.6M, EPS −$0.15
- Quarter ended Dec 31, 2022 (from the annual report): revenue −$1.48B (down 442.9% year over year), net income −$83.5M, EPS −$0.17
- Quarter ended Sep 30, 2022: revenue $857M (up 100.6% year over year), net income −$75.5M, EPS −$0.16
- Quarter ended Jun 30, 2022: revenue $847M (up 105.3% year over year), net income −$104M, EPS −$0.22
- Quarter ended Mar 31, 2022: revenue $874M (up 336.5% year over year), net income −$75.5M, EPS −$0.16
- Quarter ended Dec 31, 2021 (from the annual report): revenue $432M, net income −$187M, EPS −$0.43
- Quarter ended Sep 30, 2021: revenue $427M, net income −$34.5M, EPS −$0.08
CLOV cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$66.9M, share buybacks $18.3M
- Fiscal year ended Dec 2024: operating cash flow $34.8M, share buybacks $1.77M
- Fiscal year ended Dec 2023: operating cash flow −$145M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow −$204M, share buybacks $0
- Fiscal year ended Dec 2021: operating cash flow −$282M, share buybacks $147K
CLOV balance sheet
- Jun 30, 2026: cash n/a, total assets $720M, total liabilities $344M, shareholders' equity $376M
- Mar 31, 2026: cash n/a, total assets $698M, total liabilities $358M, shareholders' equity $339M
- Dec 31, 2025: cash $78.3M, total assets $541M, total liabilities $232M, shareholders' equity $309M
- Sep 30, 2025: cash n/a, total assets $560M, total liabilities $219M, shareholders' equity n/a
- Jun 30, 2025: cash n/a, total assets $575M, total liabilities $231M, shareholders' equity $344M
- Mar 31, 2025: cash n/a, total assets $584M, total liabilities $248M, shareholders' equity $336M
- Dec 31, 2024: cash $195M, total assets $581M, total liabilities $240M, shareholders' equity $341M
- Sep 30, 2024: cash $288M, total assets $653M, total liabilities $311M, shareholders' equity n/a
What is CLOV's revenue?
CLOVER HEALTH INVESTMENTS CO reported $2.48B of revenue over its last four quarters, through June 30, 2026.
Is CLOV profitable?
No. CLOVER HEALTH INVESTMENTS CO lost $18.4M over the last four quarters.